Tirzepatide, a novel medication, is creating significant interest in the scientific community as a potential treatment for both diabetes, type 2 and reducing body fat. This groundbreaking drug works by activating two distinct receptors, GLP-1 and GIP, leading to better blood sugar levels and notable fat loss in research studies . While early result